Advances in Infant Formula Science.


Journal

Annual review of food science and technology
ISSN: 1941-1421
Titre abrégé: Annu Rev Food Sci Technol
Pays: United States
ID NLM: 101561951

Informations de publication

Date de publication:
25 03 2019
Historique:
entrez: 26 3 2019
pubmed: 26 3 2019
medline: 20 6 2020
Statut: ppublish

Résumé

Human milk contains a plethora of nutrients and bioactive components to help nourish the developing neonate and is considered the "gold standard" for early life nutrition-as befits the only food "designed" by evolution to feed human infants. Over the past decade, there is considerable evidence that highlights the "intelligence" contained in milk components that contribute to infant health beyond basic nutrition-in areas such as programming the developing microbiome and immune system and protecting against infection. Such discoveries have led to new opportunities for infant milk formula (IMF) manufacturers to refine nutritional content in order to simulate the functionality of breast milk. These include the addition of specialized protein fractions as well as fatty acid and complex carbohydrate components-all of which have mechanistic supporting evidence in terms of improving the health and nutrition of the infant. Moreover, IMF is the single most important dietary intervention whereby the human microbiome can be influenced at a crucial early stage of development. In this respect, it is expected that the complexity of IMF will continue to increase as we get a greater understanding of how it can modulate microbiota development (including the development of probiotics, prebiotics, and synbiotics) and influence long-term health. This review provides a scientific evaluation of key features of importance to infant nutrition, including differences in milk composition and emerging "humanized" ingredients.

Identifiants

pubmed: 30908947
doi: 10.1146/annurev-food-081318-104308
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-102

Auteurs

Grace J Ahern (GJ)

APC Microbiome Ireland, University College Cork, Cork T12 YT20, Ireland.
Teagasc Food Research Centre, Moorepark, Fermoy, Cork P61 C996, Ireland; email: catherine.stanton@teagasc.ie.
School of Microbiology, University College Cork, Cork, Ireland.

A A Hennessy (AA)

Teagasc Food Research Centre, Moorepark, Fermoy, Cork P61 C996, Ireland; email: catherine.stanton@teagasc.ie.

C Anthony Ryan (CA)

Department of Paediatrics and Child Health, University College Cork, Cork, Ireland.
School of Medicine, University College Cork, Cork T12 K8AF, Ireland.

R Paul Ross (RP)

APC Microbiome Ireland, University College Cork, Cork T12 YT20, Ireland.
Teagasc Food Research Centre, Moorepark, Fermoy, Cork P61 C996, Ireland; email: catherine.stanton@teagasc.ie.
School of Microbiology, University College Cork, Cork, Ireland.

Catherine Stanton (C)

APC Microbiome Ireland, University College Cork, Cork T12 YT20, Ireland.
Teagasc Food Research Centre, Moorepark, Fermoy, Cork P61 C996, Ireland; email: catherine.stanton@teagasc.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH